WaveMan · Form 4
Bvf Gp Holdings LLC insider trades
> Search tickers & screens ⌘K
LIVE

Bvf Gp Holdings LLC insider trades

Bvf Gp Holdings LLC has filed 7 Form 4s with the SEC that we hold, for RAIN (Director, 10% owner), XOMA Royalty Corp (XOMA) (10% owner), Crescent Biopharma, INC. (CBIO) (10% owner) and MoonLake Immunotherapeutics (MLTX) (Director, 10% owner), among 5 companies in all. Across all of them we count 15 purchases worth $10.6M and 2 sales worth $10.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 265,316 shares of XOMA Royalty Corp worth $7.2M, dated 2025-05-16. The first filing on our record is dated 2021-09-15 and the latest 2025-06-17.

RAIN (RAIN)

Director, 10% owner · 2 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-13P, purchase reported on Form 4213,246$3.5M2021-09-15
2021-09-13P, purchase reported on Form 420,512$338.2K2021-09-15
2021-09-13P, purchase reported on Form 4158,511$2.6M2021-09-15
2021-09-21P, purchase reported on Form 4590$8.2K2021-09-23
2021-09-21P, purchase reported on Form 46,341$88.4K2021-09-23
2021-09-21P, purchase reported on Form 44,102$57.2K2021-09-23

XOMA Royalty Corp (XOMA)

10% owner · 2 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-09-23P, purchase reported on Form 49,885$163.1K2022-09-27
2022-09-23P, purchase reported on Form 46,715$110.8K2022-09-27
2022-09-26P, purchase reported on Form 43,021$50.8K2022-09-27
2022-09-26P, purchase reported on Form 43,339$56.2K2022-09-27
2022-09-27P, purchase reported on Form 41,004$17.0K2022-09-27
2022-09-27P, purchase reported on Form 4678$11.5K2022-09-27
2025-05-16S, sale reported on Form 4127,407$3.5M2025-05-20
2025-05-16S, sale reported on Form 4265,316$7.2M2025-05-20

Crescent Biopharma, INC. (CBIO)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MoonLake Immunotherapeutics (MLTX)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

RPTX

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-18P, purchase reported on Form 4224,388$1.9M2022-05-20
2022-05-18P, purchase reported on Form 45,730$48.7K2022-05-20
2022-05-18P, purchase reported on Form 4189,882$1.6M2022-05-20
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1803809) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms